Results 1 to 10 of about 1,409,938 (266)

Impact of COVID-19 Pandemic on the Health of Preterm Infants in Iran [PDF]

open access: yesIranian Journal of Neonatology, 2021
Background: Coronavirus disease 2019 (COVID-19) directly increases the risk of preterm delivery. Furthermore, the COVID-19 pandemic may indirectly affect the health status of preterm infants.
Mohammad Reza Zarkesh
doaj   +1 more source

Research progress on health effect of occupational exposure to radar

open access: yesShanghai yufang yixue, 2022
Radar uses electromagnetic waves to detect, track and locate objects at certain distances, which is widely used in military, meteorological, navigation and other fields. Radar emits electromagnetic waves outward and produces non-ionizing radiation, which
LAI Jiayi, JIN Kezhi
doaj   +1 more source

Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial

open access: yesFrontiers in Oncology, 2022
BackgroundProphylactic granulocyte-colony stimulating factor (G-CSF) has been shown to effectively prevent febrile neutropenia (FN) and grade 3/4 neutropenia during myelosuppressive treatment. The present study reports the clinical efficacy and safety of
Qi Mei   +18 more
doaj   +1 more source

Hyperuricemia, use of antituberculosis drugs, and liver injury: case report

open access: yesJurnal Teknologi Laboratorium, 2023
Anti-tuberculous drug can cause idiosyncratic drug-induced liver injury (DILI). Considering the benefit risk, there will discontinuation therapy and rechallenge after symptom resolve.
Vina Yuwantari   +9 more
doaj   +1 more source

Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer

open access: yesFrontiers in Oncology, 2023
BackgroundLenvatinib-pembrolizumab combination (LEAP) is an approved therapy in Japan for advanced endometrial cancer, based on the data from the KEYNOTE-775 clinical trial.
Yuki Matsuura   +8 more
doaj   +1 more source

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review

open access: yesFrontiers in Oncology, 2022
BackgroundImmune checkpoint inhibitors, including anti-PD-1 therapies, have prolonged overall survival in patients with a variety of cancers, and immunotherapy is sometimes associated with immune-related adverse events (irAEs); however, hematological ...
Qiaoyun Tan   +4 more
doaj   +1 more source

Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle

open access: yesVaccines, 2021
The immune-acquired responses after vaccination vary depending on the type of vaccine and the individual. The purpose of this study was to investigate the relationship between the acquisition of immunity and the side effects, health status, and lifestyle
Hyunji Choi   +7 more
doaj   +1 more source

Questionnaire Survey of Possible Association of Allergic Diseases with Adverse Reactions to SARS-CoV-2 Vaccination

open access: yesVaccines, 2021
To protect against COVID-19, SARS-CoV-2 vaccines have been widely used. Besides anaphylaxis, some less severe adverse effects may occur at higher frequencies.
Hiroki Morimoto   +9 more
doaj   +1 more source

On Perception and Consciousness in HPPD: A Systematic Review

open access: yesFrontiers in Neuroscience, 2021
Hallucinogen-persisting perception disorder (HPPD) features as a diagnostic category in the DSM-5, ICD-11, and other major classifications, but our knowledge of the phenomenology of the perceptual symptoms involved and the changes in consciousness during
Pieter J. Vis   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy